Ascentage Pharma Group International (AAPG) Inventory (2023 - 2025)

Ascentage Pharma Group International (AAPG) has reported Inventory for 3 consecutive years, with $4.0 million the latest figure, recorded in Q4 2025.

• Quarterly Inventory rose 339.34% year-over-year to $4.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.0 million (up 339.34% YoY) and the FY2025 annual result came in at $4.1 million, up 352.65% from the prior year.
• Inventory grew to $4.0 million in Q4 2025 per AAPG's latest filing, from $1.2 million in the prior quarter.
• Over the last five years, Inventory for AAPG reached as high as $4.0 million in Q4 2025 and fell as low as $918406.1 in Q4 2024.
• A 3-year average of $2.1 million and a median of $1.7 million in 2023 frame the typical range for Inventory.
• Annual changes were most pronounced in 2024 — Inventory tumbled 59.1% — and 2025, when it soared 339.34%.
• Year by year, Inventory stood at $2.2 million in 2023, then slumped by 59.1% to $918406.1 in 2024, then surged by 339.34% to $4.0 million in 2025.
• According to Business Quant data, Inventory over the past three periods registered $4.0 million, $1.2 million, and $918406.1 for Q4 2025, Q2 2025, and Q4 2024 respectively.